SEC 13F Intelligence

Praetorian Pr LLC / INMB

Praetorian Pr LLC’s Inmune Bio Inc Position

Does Praetorian Pr LLC own Inmune Bio Inc (INMB)? Not currently — the last reported position was 865.0K shares worth $7M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q1 2025
Shares
865.0K
% of Portfolio
+2.92%
Quarters Held
4
position exited

Position History INMB

Reported value by quarter
Q2 ’24: $4MQ2 ’24Q3 ’24: $4MQ3 ’24Q4 ’24: $4MQ4 ’24Q1 ’25: $7MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025865.0K$7M+2.92%
Q4 2024812.2K$4M+1.52%
Q3 2024780.8K$4M+1.64%
Q2 2024485.0K$4M+1.57%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Praetorian Pr LLC’s full portfolio or all institutional holders of INMB.